Urihk Pharmaceuticals
  • Home
  • About Us
    • Our Team
    • The Urihk Partnership
  • Products
    • Antibiotic
    • Antifungal
    • Antioxidant
    • Immuno modulator
    • Neuro/CNS
  • Services
  • Learn More
    • News
    • Gallery
    • Careers
  • Contact Us
Select Page
Back
Correlation of Missed Doses of Enoxaparin
Oct 25, 2021

Correlation of Missed Doses of Enoxaparin

Efficacy and safety of low-molecular-weight heparin in patients with sepsis
Oct 25, 2021

Efficacy and safety of low-molecular-weight heparin in patients with sepsis

IV Versus Subcutaneous Enoxaparin in Critically Ill Infants and Children
Oct 25, 2021

IV Versus Subcutaneous Enoxaparin in Critically Ill Infants and Children

Outcomes of thromboprophylaxis with enoxaparin vs unfractionated heparin in medical inpatients
Oct 25, 2021

Outcomes of thromboprophylaxis with enoxaparin vs unfractionated heparin in medical inpatients

ABOUT URIHK

URIHK pharmaceuticals is a wholly owned subsidiary of UREKA Hong Kong Ltd. We are a vertically integrated pharmaceutical company that launches, registers and distributes innovative products in India.
 

SITEMAP

About Us

Services

Products

Careers

Privacy Policy

CONTACT US

602-603, Sai Samarth Business Park,
Deonar, Govandi (East),
Mumbai (400088), India
Phone: +91 22 497 01103 / 43286
Email: [email protected]